Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial

OBJECTIVE: To evaluate whether the efficacy and safety of menatetrenone for the treatment of osteoporosis is noninferior to alfacalcidol in Chinese postmenopausal women. METHOD: This multicenter, randomized, double-blinded, double-dummy, noninferiority, positive drug-controlled clinical trial was co...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yan, Zhang, Zhen-Lin, Zhang, Zhong-Lan, Zhu, Han-Min, Wu, Yi-Yong, Cheng, Qun, Wu, Feng-Li, Xing, Xiao-Ping, Liu, Jian-Li, Yu, Wei, Meng, Xun-Wu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890406/
https://www.ncbi.nlm.nih.gov/pubmed/24426779
http://dx.doi.org/10.2147/CIA.S54107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890406/
https://www.ncbi.nlm.nih.gov/pubmed/24426779
http://dx.doi.org/10.2147/CIA.S54107

Ejemplares similares